OBJECTIVE: We performed a cohort study in seven hospitals in Spain to determine the clinical characteristics of incident patients with bladder cancer, the diagnostic process, and the conditions that might affect health care interval times. RESULTS: 314 patients with bladder cancer were included, 70.3 (Standard Deviation [SD] 11.2) years old and 85.0% male. Clinical stage was T1 in 45.9% of patients. The median interval time between first consultation and diagnosis was of 104.0 days (Inter quartile range [IQR]:112.0; range from 0 to 986), being shorter for those patients who attended a hospital for their first consultation. The median interval time between diagnosis and first treatment was of 0.0 days (IQR: 0.0; range from 0 to 366), being l...
Background: The Bladder Cancer Index (BCI) is so far the only instrument applicable across all bladd...
Objectives: To study diagnostic delay in invasive bladder cancer in a population-based material with...
Background: The Bladder Cancer Index (BCI) is so far the only instrument applicable across all bladd...
We performed a cohort study in seven hospitals in Spain to determine the clinical characteristics of...
OBJECTIVE: We performed a cohort study in seven hospitals in Spain to determine the clinical charac...
Background: Little is known about the healthcare process for patients with prostate cancer, mainly b...
Little is known about the healthcare process for patients with prostate cancer, mainly because hospi...
The purpose of this study is to investigate whether a prolonged delay in diagnosis of bladder cancer...
The therapeutic approach of bladder cancer strongly determines its prognosis. We describe the treatm...
BACKGROUND: Little is known about the healthcare process for patients with prostate cancer, mainly b...
The therapeutic approach of bladder cancer strongly determines its prognosis. We describe the treatm...
Introduction: The Authors describe the results of a retrospective study that analyzes importance of ...
Abstract Background: Bladder cancer is the ninth most commonly diagnosed malignancy worldwide. The ...
BACKGROUND: Despite the embedding of bladder cancer management in European guidelines, large variati...
Purpose: To investigate the symptoms and delays in the clinical pathway of bladder cancer (BC).Metho...
Background: The Bladder Cancer Index (BCI) is so far the only instrument applicable across all bladd...
Objectives: To study diagnostic delay in invasive bladder cancer in a population-based material with...
Background: The Bladder Cancer Index (BCI) is so far the only instrument applicable across all bladd...
We performed a cohort study in seven hospitals in Spain to determine the clinical characteristics of...
OBJECTIVE: We performed a cohort study in seven hospitals in Spain to determine the clinical charac...
Background: Little is known about the healthcare process for patients with prostate cancer, mainly b...
Little is known about the healthcare process for patients with prostate cancer, mainly because hospi...
The purpose of this study is to investigate whether a prolonged delay in diagnosis of bladder cancer...
The therapeutic approach of bladder cancer strongly determines its prognosis. We describe the treatm...
BACKGROUND: Little is known about the healthcare process for patients with prostate cancer, mainly b...
The therapeutic approach of bladder cancer strongly determines its prognosis. We describe the treatm...
Introduction: The Authors describe the results of a retrospective study that analyzes importance of ...
Abstract Background: Bladder cancer is the ninth most commonly diagnosed malignancy worldwide. The ...
BACKGROUND: Despite the embedding of bladder cancer management in European guidelines, large variati...
Purpose: To investigate the symptoms and delays in the clinical pathway of bladder cancer (BC).Metho...
Background: The Bladder Cancer Index (BCI) is so far the only instrument applicable across all bladd...
Objectives: To study diagnostic delay in invasive bladder cancer in a population-based material with...
Background: The Bladder Cancer Index (BCI) is so far the only instrument applicable across all bladd...